Athero Review - Issue 3/2019

Editorial

123
Editorial

Guidelines

126
A statement of the Committee of the Czech Society for Atherosclerosis on the 2019 ESC/EAS Recommendations for the diagnosis and treatment of dyslipidemia

Michal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová Za Výbor Čsat


138
Specificities of the treatment for vascular system diseases in patients with a chronic renal disease

Petr Táborský

145
The effect of statins on podocytes in nephrotic syndrome

Peter Habara, Marie Claire Šmůlová, Pavla Fialová, Jan Krtil, Karolína Krátká, Ivan Rychlík

153
Dyslipidemia in patients with chronic kidney disease

Magdaléna Dušejovská, Marek Vecka, Ivan Rychlík, Aleš Žák

159
Apolipoprotein L1 – ethnically specific determinant of renal and heart failure

Jaroslav A. Hubáček


clinical studies

162
Observational study of dyslipidemia management in the Czech Republic

Lukáš Zlatohlávek, Michaela Šnejdrlová, Ian Bridges, Romana Šindelářová


171
Lysosomal acid lipase deficiency: one of the possible causes of dyslipidemia and hepatopathy

Eva Tůmová, Michal Vrablík

176
Vitamin D and coronary artery risk detected by computed tomography

Dominik Pella, Claudia Gibarti, Zuzana Pella, Jozef Gonsorčík


181
Ten ways of using ezetimibe, or a brief guide to its use today

Martin Šatný, Michal Vrablík

185
A strategy for cardiovascular prevention: that’s what matters!

Michal Vrablík


189
Rešerše zajímavých článků ze zahraniční literatury

Eva Tůmová


Annoucements

191
Fellowship ČSAT: German Heart Center Munich – Technical University Munich 18. 2. 2019–17. 8. 2019

Martin Šatný

193
Šobrův den 2019: Lipidologie opět na výsluní

Kristýna Čillíková


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account